An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities.
Study Design
- Tipo di studio
- In Vitro
- Popolazione
- Human gut microflora in chemostat culture
- Intervento
- An in vitro assessment of the effects of broad-spectrum antibiotics on the human gut microflora and concomitant isolation of a Lactobacillus plantarum with anti-Candida activities. Tetracycline, nystatin
- Comparatore
- Control culture
- Esito primario
- Gut microflora populations
- Direzione dell'effetto
- Negative
- Rischio di bias
- Unclear
Abstract
Chemostat culture was used to determine the effects of the antimicrobial agents tetracycline and nystatin on predominant components of the human gut microflora. Their addition to mixed culture systems caused a non-specific, and variable, decrease in microbial populations, although tetracycline allowed an increase in numbers of yeasts. Both had a profound inhibitory effect upon populations seen as important for gut health (bifidobacteria, lactobacilli). However, a tetracycline resistant Lactobacillus was enriched from the experiments. A combination of genotypic and phenotypic characterisation confirmed its identity as Lactobacillus plantarum. This strain exerted powerful inhibitory effects against Candida albicans. Because of its ability to resist the effects of tetracycline, this organism may be useful as a probiotic for the improved management of yeast related conditions such as thrush and irritable bowel syndrome.
TL;DR
Because of its ability to resist the effects of tetracycline, this organism may be useful as a probiotic for the improved management of yeast related conditions such as thrush and irritable bowel syndrome.
Used In Evidence Reviews
Similar Papers
The American journal of gastroenterology · 2000
Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome.
European journal of gastroenterology & hepatology · 2001
A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
PloS one · 2012
A meta-analysis of probiotic efficacy for gastrointestinal diseases.
World journal of gastroenterology · 2012
Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
Digestive diseases and sciences · 2002
Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.
Journal of clinical gastroenterology · 2012